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Background: A single nucleotide polymorphism (SNP) in the first intron of the myostatin gene (MSTN) is associated with
aptness of elite Thoroughbreds to race over sprint, middle or long distances. This intronic marker (g.66493737 T≻ C), a
short interspersed nuclear element (SINE) of 227 bp (Ins227bp) insertion polymorphism in the MSTN promoter, and the
adjacent SNP BIEC2-417495 have not been studied for their association with racing aptness of the average Thoroughbreds
raced in countries with lower status of the racing industry. This study investigated these markers regarding their
prevalence and association with performance in common race horses. Markers were genotyped by amplification
refractory mutation system-quantitative PCR (ARMS-qPCR) or amplicon melting. Furthermore, we asked whether the
Ins227bp marker might theoretically regulate the expression of myostatin by generating a novel target for DNA
methylation or by changing binding sites for transcription factors. Putative sites for DNA methylation or binding of
transcription factors were predicted by MethPrimer and by the softwares JASPAR, MatInspector and UniPROBE,
respectively.
Results: Pairwise linkage disequilibrium between g.66493737 T≻ C and Ins227bp was high (r2 = 0.93). A lower linkage
was determined for g.66493737 T≻ C and BIEC2-417495 (r2 = 0.69) as well as for BIEC2-417495 and Ins227bp (r2 = 0.76).
The estimated frequencies for the presence of Ins227bp (I) indel and the C alleles at g.66493737 T≻ C and BIEC2-417495
were 0.46, 0.47 and 0.43, respectively. Heterozygotes represented the most abundant genotype at each locus. The
best racing distance (BRD) was significantly different between the homozygotes of each SNP (p = 0.01 to 0.03).
C allele homozygotes at BIEC2-417495 or g.66493737 T ≻ C, as well as Ins227bp homozygotes earned most money
on a mean distance ranging from 1211 to 1230 m. Heterozygotes earned most money on races over 1690 to
1709 m. The BRD for the T/T carriers at both SNP loci and for the SINE-free genotype was 1812 to 1854 m. Other
performance parameters were not significantly different between the genotypes, except of the relative success
score (RSS). The RSS was significantly slightly better on a distance of ≤1300 m for all carriers of the C allele and the
Ins227bp compared to homozygous T genotypes and SINE-negative horses (p = 0.037 to 0.046). For distances of
more than 1300 m the RSS was not significantly different between genotypes.
In silico assessment indicated that the Ins227bp promoter insertion might have generated a CpG island and a few
novel putative binding sites for transcription factors.
Conclusions: All three target polymorphisms (Ins227bp, g.66493737 T ≻ C, BIEC2-417495) are suitable markers to
assess the ability of non-elite Thoroughbreds to race at short or longer distances. The CpG island generated by
Ins227bp may cause training-induced silencing of MSTN expression.* Correspondence: Rene.vandenHoven@vetmeduni.ac.at
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The g.66493737 T ≻C marker located in the first intron of
the MSTN gene predicts the racing ability of Thorough-
breds based on the quantitative traits best racing distance
(BRD) or win-race distance [1–3]. C/C homozygotes ap-
pear better suited for fast, short-distance races (≤1300 m),
whereas C/T genotypes seem to compete better in middle-
distance races (1301 to 1900 m), while T/T homozygotes
perform generally better over longer distances (>2114 m)
[1, 2]. For two cohorts of elite horses a strong association
was demonstrated for the C and T alleles with the sprint-
ing or staying performance, respectively [3, 4].
A distant SNP, BIEC2-417495 (Fig. 1), located 692 kb or
30 kb upstream of MSTN or glutaminase (GLS) genes,
respectively, is similarly associated with racing aptness [5].
The highest standard and most valuable elite Flat races
are known as Group (Stakes) races, whereas Listed races
are the next in status. The elite Thoroughbreds de-
scribed before had won at least one Group race or a
Listed race. Most previous studies have been performed
with elite cohorts from countries with the most internation-
ally regarded Thoroughbred industry. Such cohorts likely
do not represent the population of Thoroughbreds raced in
countries in which horse racing is regarded to be of poorer
quality on an international level. It would be very interest-
ing to see if the association between MSTN markers and
best racing distance or other performance indicators holds
true in a less well regarded Thoroughbred population.
Therefore, we present an observational study on the previ-
ously identified variants in the equine MSTN, thought to
influence the racing ability of Thoroughbred horses. For
this we studied a cohort of 56 non-elite Thoroughbreds
raced in Austria and Turkey. Races run were usually handi-
cap races or other non-Group or non-Listed races.
It is currently not understood how the g.66493737
T ≻C polymorphism, located in the middle of a rela-
tively large intron (1.829 bp), may influence the expres-
sion of genes involved in the development of juvenile
and mature equine muscles. Moreover, although some
marginal increase in muscle mass has been described
[6], the massive increase in muscle mass seen in other
species with MSTN missense or nonsense mutations
such as in knock-out mice [7], double muscled cattle
[8, 9] or “bully” whippets [10] was not observed. TheFig. 1 Location of the target polymorphisms on chromosome 18. Only the
are depictedSINE of the MSTN promoter, Ins227bp, is in high link-
age disequilibrium (r2 = 0.73 to 1) with the C allele at
g.66493737 T ≻C [2, 11], but considered less appropriate
to predict racing aptness [2]. Recently, haplotype data sug-
gested that Ins227bp is contemporary to and arose upon a
haplotype containing the C allele at g.66493737 T ≻C
[11]. Moreover, it is suggested that Ins227bp, rather than
the intron 1 SNP of MSTN, drives muscle fiber type char-
acteristics and is the variant targeted by selection for
short-distance racing [11].
To find a possible mechanism for this, we analysed the
sequence in silico to identify putative binding sites for
DNA methylation and transcription factors resulting from
insertion of the Ins227bp polymorphism.
Results and Discussion
Linkage disequilibrium and allelic distribution
Compared to the study by Hill et al. [2] our experimental
cohort of average Thoroughbreds was different in linkage
disequilibrium pairwise tested for g.66493737 T ≻C and
Ins227bp as well as for g.66493737 T ≻C and BIEC2-
417495 (r2 values of 0.73 versus 0.93 and 0.86 versus 0.69,
respectively see Additional file 1: Figure S1). The lower
disequilibrium observed between g.66493737 T ≻C and
BIEC2-417495 makes it less difficult to assess the functional
impact of either locus independent of the other. Table 1
displays the distribution of the Ins227bp, g.66493737 T ≻C
and the BIEC2-417495 alleles in the cohort of 56 non-elite
Thoroughbreds.
The estimated frequencies for the presence of Ins227bp
(I) indel and the C alleles at g.66493737 T ≻C and BIEC2-
417495 were 0.46, 0.47 and 0.43, respectively. Heterozy-
gotes represented the most abundant genotype for all
mutations (Ins227bp: 59 % I/N, 16 % I/I and 25 % N/N;
g.66493737 T ≻C: 59 % C/T, 18 % C/C and 23 % T/T;
BIEC2-417495: 50 % C/T, 18 % C/C and 32 % T/T).
Performance indicators
There was no statistically significant difference in victor-
ies, places and shows, starts, life earnings, best earnings
in a race and average earning per start between the
genotypes for each marker (Table 2). However, the BRD
was significantly different between some of the geno-
types (Table 2). The RSS was calculated for distancesgenes (in italics) most closely surrounding the three markers
Table 1 Distribution of marker alleles across the cohort of
non-elite horses (n = 56)
BIEC2-417495 Ins227bp g.66493737C/T
18 T/T 14 N/N 4 I/N 13 T/T 5 C/T
28 C/T 27 I/N 26 C/T
1 II 2 C/C
10 C/C 8 I/I 2 IN 8 C/C 2 C/T
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distance, the RSS determined for the C/C and C/T
genotypes at g.66493737 T ≻ C was significantly higher
compared to T/T carriers (p = 0.037 and p = 0.046,
respectively). I/I genotypes had a marginally significant
better RSS than the N/N genotypes (p = 0.052). For the
BIEC2-417495 genotypes no difference in RSS was
found for the short distance neither for distances more
than 1300 m.
Sampling bias in this study could not be prevented
since assessment of the racing ability was based onTable 2 Mean ± sd of the performance indicators per marker genot
BIEC2-417495
C/C
Victories 2.2 ± 2.5
Place & shows 8.6 ± 7.7
Races run 20.7 ± 14.9
Life earnings (€) 20261 ± 18749
Best racing distance (m) 1211 ± 537a
Best race earnings (€) 5578 ± 5708
Earnings/start (€) 919 ± 917
C/T
Victories 2.3 ± 2.3
Place & shows 6.6 ± 6.1
Races run 17.5 ± 12.5
Life earnings (€) 28784 ± 32105
Best racing distance (m) 1690 ± 361
Best race earnings (€) 7890 ± 8184
Earnings/start (€) 1626 ± 1909
T/T
Victories 3.1 ± 4.0
Place & shows 8.4 ± 10.1
Races run 22.4 ± 25.0
Life earnings (€) 30382 ± 43537
Best racing distance (m) 1822 ± 416a
Best race earnings (€) 6074 ± 6655
Earnings/start (€) 1122 ± 1272
ap = 0.01
bp = 0.03 cp = 0.02
dp = 0.03 ep = 0.01
Corresponding letters per column indicate significance pairwise difference (Dunn’sresults of races run on different tracks under different
circumstances and over a wide range of distances. This
forced us to cluster race distance slightly differently as
was done by others [1, 3]. Considering maximum speed
of a Thoroughbred, a real sprint distance should not be
more than 1000 m [12]. We chose 1300 m as the nearest
suitable approximation of a sprint distance to obtain a
sufficient number of performances data. The same rea-
son requested others to make a slightly different split at
1600 m [1]. Existing data provide evidence that the pro-
portion of anaerobic power decreases to less than 5 % if
races are 2400 m or longer [13]. Thus, the empirical
classification of distances ranging between 1000 and
2400 m according to the International Federation of
Horseracing Authorities (www.horseracingintfed.com)
should be regarded as arbitrary. In this respect, the BRD
for the C/C (and I/I) genotypes on average fell within
the physiological “sprint” distance (<1400 m). Ranges of
BRD between the C/T (I/N) and T/T (N/N) genotypes
did overlap considerably, as was also reported by othersype
INS227bp g.66493737 T ≻ C
I/I C/C
2.1 ± 2.5 1.9 ± 2.4
9.1 ± 7.7 8.3 ± 7.7
18.8 ± 11.7 17.6 ± 11.77
22860 ± 18398 20638 ± 18714
1211 ± 537b,c 1230 ± 510d,e
5992 ± 5797 5457 ± 5722
1,214 ± 961 1102 ± 973
I/N C/T
2.6 ± 2.9 2.7 ± 2.9
6.7 ± 5.8 6.8 ± 5.8
19.8 ± 18.7 19.8 ± 18.7
28,823 ± 33785 29226 ± 33513
1709 ± 347 b 1705 ± 351d
7376 ± 7818 7663 ± 7730
1441 ± 1812 1498 ± 1797
N/N T/T
2.7 ± 3.4 2.9 ± 3.5
8.4 ± 10.4 8.9 ± 10.7
19.8 ± 19.0 20.8 ± 19.4
28471 ± 43456 29620 ± 45009
1812 ± 461c 1854 ± 454e
6297 ± 7127 6028 ± 7343
1162 ± 1374 1103 ± 1412
Test)
Table 3 Mean and standard deviation of RSS per genotype for
sprint and longer distance and number of starts on these
distances
BIEC2-417495 INS227bp g.66493737 T ≻ C
C/C I/I C/C
RSS for:
≤1300 m 3.5 ± 2.3 3.6 ± 2.5a 3.3 ± 2.5b
>1300 m 2.6 ± 1.6 2.8 ± 3.0 2.6 ± 1.6
races ≤1300 m 8.6 ± 10.0 8.5 ± 10.7 7.8 ± 10.4
races >1300 m 10.2 ± 9.4 8.8 ± 5.5 8.3 ± 5.4
C/T I/N C/T
RSS for:
≤1300 m 2.6 ± 2.9 2.8 ± 3.0 3.0 ± 3.0c
>1300 m 2.9 ± 1.4 2.8 ± 3.0 2.8 ± 1.4
races ≤1300 m 2.8 ± 3.4 2.9 ± 3.2 3.0 ± 3.2
races >1300 m 14.2 ± 10.9 16.3 ± 17.5 16.3 ± 17.5
T/T N/N T/T
RSS for:
≤ 1300 m 2.0 ± 2.8 1.4 ± 1.9a 1.1 ± 1.7b,c
>1300 m 2.8 ± 1.3 2.9 ± 1.3 3.0 ± 1.3
races≤ 1300 m 3.2 ± 6.0 4.0 ± 6.1 3.5 ± 7.0
races >1300 m 19.7 ± 23.0 15.3 ± 15.8 18.0 ± 16.1
ap = 0.05
bp = 0.037 cp = 0.046
Corresponding letters within a column indicate significance pairwise difference
(Dunn’s Test)
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more factors determine the racing success of a horse.
Nevertheless, the pattern confirms the underlying gen-
etic aptness for a specific distance and could be used by
the trainer to strategically design a horse’s racing career.
Horses were identified as non-elite due to their non-
competing status in Group or Listed races. However,
there was a large variation in price money won and
some might have become elite horses in the hands of
other trainers. We tried to estimate the strength of the
associations of the genotypes and racing aptness in the
general horse population, however the sample size of 56
horses was too small to allow further analyses of associ-
ation between genotype and racing performance. Sample
sizes of at least 200 horses and even more than 4500 in
case of victories would have been needed to obtain a min-
imal power of 0.80. Therefore, it is not surprizing that in
other studies with larger cohorts BRD was often the only
trait that was significantly associated with genotype [1–4].
Although our BRD was not based on winning races,
instead being determined by distance of race in which the
horse earned most money, the association with the geno-
types of g.66493737 T ≻C in our non-elite race horse
population agrees with that described for cohorts of elite
and better quality horses [1–4]. The proportion of C/Chomozygotes in our non-elite cohort was dissimilar to
those given by Hill et al. [2] (18 % versus 29 %), but similar
to that of Tozaki et al. [4]. The proportion of T/T homo-
zygotes in our cohort was similar to that of Hill et al. [2]
but smaller than that of Tozaki et al. [4] (23 % versus
31 %), likely explained by the different origins of the
populations.
The Nearctic-Northern Dancer sire line is strongly
associated with dispersion of the C/C genotype at
g.66493737 T ≻ C [11]. Our cohort did not confirm this
finding. The mean percentage of Nearctic blood in our
g.66493737 T ≻ C C/C horses was not higher (p = 0.4)
than in the C/T and T/T horses. Similar trends were
found for the other two markers (data not shown).
The C allele is not unique for Thoroughbreds and
Thoroughbred-derived populations. It was even found at
a high frequency in Shetland ponies (0.32 to 0.50) and
Fulani horses (0.33) [11, 14]. In contrast, the Ins227bp
marker appears to be more specific for Thoroughbreds,
Quarter horses and related breeds and is distributed
across other breeds only at minor frequency [11, 15].
The reason of the statistical association of the MSTN
polymorphism with racing aptness is still unknown be-
cause the strongest marker for this trait, BIEC2-417495
[2], is located far upstream (692 kb) of MSTN near the
locus of the glutaminase (GLS) gene. This mitochondrial
enzyme is assumed to play a role in energy production.
So far, this gene or its alleles have not been studied in
the horse (www.omin.org/entry/138280).
Nevertheless, the C allele of g.66493737 T ≻C is
regarded as a marker for muscularity [1–4]. Inconsist-
ently, the tightly associated Ins227bp insertion poly-
morphism [2, 11], however, was not found to affect
muscle mass [16]. Thus, a possible effect of the C allele
on muscle mass needs further confirmation. Although
the MSTN polymorphisms may not clearly affect mature
muscle mass, they might influence prenatal muscle dif-
ferentiation and juvenile composition. In Quarter Horses
and Thoroughbreds the C allele at g.66493737 T ≻C as
well as the Ins227bp marker appear to be associated
with higher and lower proportions of type 2X and type I
fibres, respectively [11, 15]. Thus, Ins227bp could indi-
cate the potential for high speed of Thoroughbreds too.
Interestingly, Thoroughbreds being homozygous for the
C allele at g.66493737 T ≻C showed rather a higher tran-
script expression of MSTN in a non-trained condition
compare to the C/T and T/T type. Only after a period of
10 months of training the expression level decreased to
similar levels as the C/T and T/T genotypes [17]. This
contradicts the simplistic hypothesis that a decreased
MSTN expression leads to increased muscle mass. Theor-
etically, the three target polymorphisms could cause a
change of MSTN expression by intron mediated enhance-
ment [18–20], a distant regulatory DNA element located
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epigenetic change of the MSTN promoter.
Novel transcription factor binding site candidates and
CpG island caused by Ins227bp
It was not very surprising that the insertion of the
227 bp SINE (Ins227bp) into the promoter of the MSTN
gene generated some novel putative binding sites for
transcription factors . In more detail, whereas the inser-
tion did not erase a putative transcription factor binding
site according to the analysis tools JASPAR, MatInspec-
tor and UniPROBE applied under stringent settings, it
created one, three or four novel putative transcription
factor binding sites according to the pairwise intersec-
tions of the three prediction programs (Fig. 2). There
was no site predicted by all three tools. More surprising,
however, was the finding that the Ins227bp insertion
created a novel CpG island (Fig. 3) including a down-
stream segment at the insertion site.
Gene expression differences that are the result of SINE
insertions are likely to be a recurrent theme in the study
of complex traits [22], however, so far very few studies
have conclusively demonstrated exaptation of transpos-
able elements as transcriptional regulatory regions [23].Fig. 2 Insertion of the SINE marker Ins227bp into the equine MSTN
promoter created one, three or four putative transcription factor
binding sites according to the pairwise intersections of predictions
obtained by the software tools JASPAR, MatInspector and UniPROBE.
The pairwise intersections contained Nkx3-2 and the closely related
Nkx3-1 (JASPAR crossed with UniPROBE), Nkx2-5, ZNF354 and MZF1
(JASPAR with MatInspector), as well as PlagI1 (twice), ZNF300 or nearly
identical ZNFs and Nkx2-5 (MatInspector with UniPROBE). The Venn
diagram was generated with eulerAPE 3.0.0 [ Micallef L, Rodgers P:
eulerAPE: Drawing Area-Proportional 3-Venn Diagrams Using Ellipses.
PLoS ONE 2014, 9: e101717]Their functioning as nucleation centres for de novo
methylation is striking in an epigenetic context [24].
Further dissecting the effects of the genetic variants will
benefit understanding the regulation of the racing ability
of Thoroughbreds. Of special interest in this regard
would be, to unravel whether the SINE Ins227bp of the
MSTN promoter would regulate MSTN expression via
the generated CpG island and/or via changed target sites
for transcriptional regulator(s).
Conclusion
Each of the the three polymorphisms studied represents
a suitable genetic marker to predict the sprinting ability
of non-elite Thoroughbreds. Future experiments with
large numbers of horses, between 200 to over 4500, de-
pending on the studied trait should address the possible
role of the SINE insertion Ins227bp as a putative cis elem-
ent enabling transcriptional regulation via association with
trans-acting factors and/or modulation by exercise. The
use of untrained age-matched controls will exclude that
methylation regulates expression of MSTN in an age-
dependent manner in horses of 20 and 30 months [17].
Methods
Animals and samples
Roots from hair samples were collected from Thorough-
breds in Austria (n = 20) and Turkey (n = 36). The life
time performance of these horses was extracted from
published race results.
Genotyping assays
The SNPs g.66493737 T ≻ C and BIEC2-417495 were
typed by ARMS-qPCR) [25]. The length polymorphism
Ins227bp was analysed by amplicon dissociation and
agarose gel electrophoresis.
Primers (Additional file 2: Table S1) were designed
with the software Primer Express 2.0 (Life Technologies,
Foster City, USA) and controlled for dimer formation
using the web tool NetPrimer (www.premierbiosoft.com/
netprimer/). Their specificity was evaluated with Primer-
BLAST of NCBI using the “nr“ database of Equus cabal-
lus. The secondary structure of the PCR product was
analysed with the Mfold software [26].
Genomic DNA was extracted from hair roots using the
NucleoSpin® Tissue Kit according to the manufacturer’s
instructions (Macherey-Nagel GmbH & Co. KG, Düren,
Germany). DNA concentration was measured spectro-
photometrically using the Hellma® TrayCell (Hellma Ana-
lytics, Müllheim, Germany) on the BioPhotometer 6131
(Eppendorf, Hamburg, Germany). Sample concentrations
ranged between 2 and 11 ng/μl. Amplification was per-
formed in duplicate 20-μl reactions. A single reaction con-
sisted of 1 × reaction buffer (70 mM Tris–HCl (pH 8.3),
50 mM KCl, 10 mM (NH4)2SO4, 0.1 mg/ml gelatin),
Fig. 3 Inserting the Ins227bp SINE into the MSTN promoter generates a novel CpG island. The 184 bp island (nucleotides 78 to 261 highlighted
by light blue background) was identified by the MethPrimer software. Red bars designate CpG dinucleotides. The integration-flanking set of
15 bp direct repeats, TAAAAAGCCACTTGG, one being part of and the other being adjacent to the SINE insertion, is depicted by arrows
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primer (Solis Biodyne, Tartu, Estonia), 1 unit hot-start Taq
DNA polymerase (HOT FIREPol® DNA Polymerase; Solis
Biodyne, Tartu, Estonia), 3 μl DNA and 0.4 × EvaGreen
(Biotium, Hayward, USA) or 200 nM hydrolysis probe
depending on the detection format used (Additional file 2:
Table S1). Cycling conditions on the StepOnePlus™ Real-
Time PCR System (Life Technologies) running under
the software version 2.0 were 95 °C for 15 min followed
by 45 cycles of 95 °C for 15 s, 58 °C for 20 s, and 60 °C
for 30 s. For dye-based qPCR (markers: Ins227bp and
g.66493737 T ≻ C) amplicon dissociation analysis from
60 °C to 95 °C with 0.3 °C/s increments and continuous
acquisition of fluorescence was performed. Specific
amplification was concluded when the target and the
no-template control showed different melting tempera-
tures. In addition, the amplicon of the Ins227bp assay was
assessed on an 1 % agarose gel stained with a 10.000-fold
dilution of the dye Midori Green Advance (Biozym Scien-
tific GmbH, Hessisch Oldendorf, Germany) and visualised
on the AlphaImager HP System (Biozym Scientific GmbH,
Hessisch Oldendorf, Germany) equipped with a blue light
screen.
A sample was considered homozygous or heterozygous
if the difference of the quantification cycle (Cq) values
obtained by the two discriminative assays of ARMS-
qPCR was ≥ 7 or ≤ 2.5, respectively.
Pairwise testing of linkage disequilibrium
Haploview 4.2 was used for pairwise testing of linkage
disequilibrium [27].
Prediction of transcription factor binding sites putatively
created by the Ins227bp insertion
Transcription factor binding sites putatively created by the
SINE insertion Ins227bp were analysed by the software
tools JASPAR (version 5.0_ALPHA) [28, 29], MatInspector
(version 8.2) [30] and UniPROBE (state of March 2015;
[31] calling upon different databases. To report only the
most likely sites stringent thresholds were applied, namely
a 90 % relative profile score threshold for JASPAR set to
“CORE Vertebrata”, a core similarity of 1.0 and a matrixsimilarity of at least 0.95 for MatInspector when set to ver-
tebrates and a score threshold of 0.48 for UniPROBE set
to mammalian which is slightly below the maximum value
of 0.50.
CpG island prediction
The CpG island was predicted by the MethPrimer software
[32] using an island size of at least 100 nucleotides, a GC
percentage of at least 50 % and an observation/expectation
CpG ratio of more than 0.6.
Calculation of relative success scores (RSS)
The various racing distances on which the horses had
performed could only suitably be clustered into: sprint
distance (≤1300 m) and non-sprint (>1300 m). A RSS
was calculated for each distance class. The algorithm for
the RSS was to sum up all points obtained in the
respective distance class, divided by the number of starts
in that class. Wins were given ten points, a 2nd place
five, a 3rd place four, a 4th place three, a 5th place two
and unplaced start was given one point. In this scoring
system wins are twice as important as a second place,
while honouring a finished race with one point allowed
to include the effects of frequent starts and indicates a
certain level of toughness. Furthermore, per genotype
group the mean victories, mean places and shows, mean
number of starts, mean life earnings, mean best racing
distance based on highest earnings, mean best earnings
in a race and mean earnings per start were calculated.
The percentage of Nearctic blood in the pedigree (Fx) was
calculated by the term Σ [0.5]x1+x2+1 [33] whereby x1 rep-
resents the number of generations from sire(s) to Nearctic
and x2 the number of generations from dam(s) to Nearc-
tic. The parameters were used to identify possible associa-
tions between Ins227bp and genotypes at BIEC2-417495
and g.66493737 T ≻C.
Statistics
Statistical analysis was performed using IBM® SPSS® version
20 (IBM Corporation, New York, United States) statistical
software. All data were tested by Shapiro-Wilks test
and appeared not normally distributed (p < 0.04). Parameter
van den Hoven et al. BMC Veterinary Research  (2015) 11:138 Page 7 of 8differences between the genotypes at each of the three
markers were analysed by a Kruskall-Wallis H omnibus
tests and significant results (p < 0.05) were further subjected
to post hoc rank tested using the Dunn’s pairwise test with
Bonferroni adjustment for multiple comparisons.
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